Definium Therapeutics, Inc.: cash_and_equivalents

Value{"amount": 120472000, "concept": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "currency": "USD"}
Period (as of 2022-03-31)
Statuscurrent
EntityDefinium Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-22-009955 · Open the official SEC filing →
Retrieved: 2026-08-19T18:15:01.473553+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001813814/cash-and-equivalents/2022-03-31 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/d4d2e4dd-374d-41b8-854a-0819a55d78ee

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies